Cargando…
ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Chongqing Medical University
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363626/ https://www.ncbi.nlm.nih.gov/pubmed/37492703 http://dx.doi.org/10.1016/j.gendis.2022.09.013 |
| _version_ | 1785076671456477184 |
|---|---|
| author | Mei, Ying Hang, Qinglei Teng, Hongqi Yao, Fan Chen, Mei-Kuang Hung, Mien-Chie Sun, Yutong Ma, Li |
| author_facet | Mei, Ying Hang, Qinglei Teng, Hongqi Yao, Fan Chen, Mei-Kuang Hung, Mien-Chie Sun, Yutong Ma, Li |
| author_sort | Mei, Ying |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10363626 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Chongqing Medical University |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103636262023-07-25 ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer Mei, Ying Hang, Qinglei Teng, Hongqi Yao, Fan Chen, Mei-Kuang Hung, Mien-Chie Sun, Yutong Ma, Li Genes Dis Rapid Communication Chongqing Medical University 2022-10-15 /pmc/articles/PMC10363626/ /pubmed/37492703 http://dx.doi.org/10.1016/j.gendis.2022.09.013 Text en © 2022 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Rapid Communication Mei, Ying Hang, Qinglei Teng, Hongqi Yao, Fan Chen, Mei-Kuang Hung, Mien-Chie Sun, Yutong Ma, Li ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer |
| title | ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer |
| title_full | ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer |
| title_fullStr | ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer |
| title_full_unstemmed | ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer |
| title_short | ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer |
| title_sort | zranb1 is an nbs1 deubiquitinase and a potential target to overcome radioresistance and parp inhibitor resistance in triple-negative breast cancer |
| topic | Rapid Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363626/ https://www.ncbi.nlm.nih.gov/pubmed/37492703 http://dx.doi.org/10.1016/j.gendis.2022.09.013 |
| work_keys_str_mv | AT meiying zranb1isannbs1deubiquitinaseandapotentialtargettoovercomeradioresistanceandparpinhibitorresistanceintriplenegativebreastcancer AT hangqinglei zranb1isannbs1deubiquitinaseandapotentialtargettoovercomeradioresistanceandparpinhibitorresistanceintriplenegativebreastcancer AT tenghongqi zranb1isannbs1deubiquitinaseandapotentialtargettoovercomeradioresistanceandparpinhibitorresistanceintriplenegativebreastcancer AT yaofan zranb1isannbs1deubiquitinaseandapotentialtargettoovercomeradioresistanceandparpinhibitorresistanceintriplenegativebreastcancer AT chenmeikuang zranb1isannbs1deubiquitinaseandapotentialtargettoovercomeradioresistanceandparpinhibitorresistanceintriplenegativebreastcancer AT hungmienchie zranb1isannbs1deubiquitinaseandapotentialtargettoovercomeradioresistanceandparpinhibitorresistanceintriplenegativebreastcancer AT sunyutong zranb1isannbs1deubiquitinaseandapotentialtargettoovercomeradioresistanceandparpinhibitorresistanceintriplenegativebreastcancer AT mali zranb1isannbs1deubiquitinaseandapotentialtargettoovercomeradioresistanceandparpinhibitorresistanceintriplenegativebreastcancer |